A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice-Reference-Cited by-同舟云学术

A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice

Published:2012-12 Issue:5 Volume:76 Page:908-920
ISSN:0896-6273
Container-title:Neuron
language:en
Short-container-title:Neuron

Author:

DeMattos Ronald B.,Lu Jirong,Tang Ying,Racke Margaret M.,DeLong Cindy A.,Tzaferis John A.,Hole Justin T.,Forster Beth M.,McDonnell Peter C.,Liu Feng,Kinley Robert D.,Jordan William H.,Hutton Michael L.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference54 articles.

1. An effector-reduced anti-beta-amyloid (Abeta) antibody with unique abeta binding properties promotes neuroprotection and glial engulfment of Abeta;Adolfsson;J. Neurosci.,2012

2. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease;Bard;Nat. Med.,2000

3. Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology;Bard;Proc. Natl. Acad. Sci. USA,2003

4. Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides;Bibl;Proteomics Clin. Appl.,2012

5. A single ascending dose study of bapineuzumab in patients with Alzheimer disease;Black;Alzheimer Dis. Assoc. Disord.,2010

Cited by 289 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent updates on immunotherapy in neurodegenerative diseases;Brain Research;2024-12

2. The growth rate of senile plaques is determined by the competition between the rate of deposition of free Aβ aggregates into plaques and the autocatalytic production of free Aβ aggregates;Journal of Theoretical Biology;2024-10

3. New insights into innate immunity in Alzheimer’s disease: from APOE protective variants to therapies;Trends in Immunology;2024-09

4. Mechanistic Approach to Immunity and Immunotherapy of Alzheimer’s Disease: A Review;ACS Chemical Neuroscience;2024-08-22

5. Engineering anti-amyloid antibodies with transferrin receptor targeting improves brain biodistribution and mitigates ARIA;2024-07-26